
The Cleveland Clinic Director of Sleep Disorders Research navigates the complexities of OSA presentation, progression, management and eradication with the Lungcast team.

The Cleveland Clinic Director of Sleep Disorders Research navigates the complexities of OSA presentation, progression, management and eradication with the Lungcast team.

This episode of DocTalk features 5 expert retina specialists discussing the top line data from the conference.

The best overall outcomes were attained in eyes without fluid and ellipsoid zone integrity preservation, investigators said.

Patients with obesity who had bariatric surgery had lower rates of mortality compared to patients who did not have bariatric surgery.

In recent years more and more biologics have come on the market for the treatment of IBD.

Data show the presence of five and six risk factors increased the risk of VTE exponentially to 10.9% and 25%, respectively

New research has suggested that approximately 2%-5% of patients with sarcoidosis also struggle with cardiac sarcoidosis.

A look into the efficacy of ozanimod in patients with UC and the potential risk for cardiovascular events.

Patients who have IPAA are more than twice as likely to suffer from male sexual dysfunction.

Steve Nissen, MD, reviews the promising phase 1 APOLLO findings, and details what needs to be investigated next for the siRNA.

New phase 1 APOLLO data show the investigative single-dose siRNA infusion may address an inherent risk factor for severe cardiovascular events.

Desai discusses the potential long-term effects of mavacamten and what it could mean for a patient population with HCM.

Findings from VALOR-HCM suggest more data is needed to assess the durability of improvement in septal reduction therapy eligibility over longer time periods.

There is no clinically meaningful differences in safety and efficacy between biologics and biosimilars.

The majority of drugs in development for IBD target inflammation.

There was not a statistically significant correlation between CDI recurrence and age, gender, previous proton pump inhibitor use, and antibiotic exposure.

Dennis Bruemmer, MD discusses new agents and perspectives on care in treating patients with type 2 diabetes at high risk of CV, renal complications.

Ulcerative colitis patients with fatigue are more likely to be unemployed, have moderate or severe disease, and higher Mayo scores.

Patients who utilized virtual and in-person visits had comparable numbers of follow-ups, referrals, and outpatient surgeries.

An assessment of VISTA and VIVID patient data uncovered surprising risk factors associated with aflibercept success or failure in DME resolution.

A trio of experts from the Cleveland Clinic join Dr. Rizzo for a talk on lung transplant trends and challenges in the US.

Increased cumulative smoking was associated with increased risk of hospitalization and death.

Despite the difficult circumstances, experts believe colorectal cancer rates will not decrease in the coming years due to delays in screenings.

COVID-19 positive patients with COPD demonstrated a greater risk for hospitalization, ICU admission, and need for invasive mechanical ventilation compared with non-COPD patients.

Blood supply shortages have underscored a need to develop new strategies which limit transfusions and triage blood products.

As of February, 121 unique therapies are involved in clinical trials for Alzheimer disease, with putative disease-modifying agents targeting disease onset or progression accounting for the largest number.

A secondary ACCELERATE assessment shows a particular set of patients who may benefit from Lp(a)-lowering novel agents.

What is the primary care physician's role in detecting the rare hepatologic condition?

A Cleveland Clinic study showed about 13% of its transfusions were in deference to current guidelines. That said, there's plenty of gray area for cause of care.

The fully active robot and accompanying preparation software provides surgeons capability to individualize strategy pre-operation.